Hyderabad: Union Ministry of Health has finalised arrangements with Hyderabad-based vaccine manufacturer Biological E to reserve 30 crore Covid-19 vaccine doses.
These vaccine doses will be manufactured and stockpiled by Biological E from August-December 2021. For this purpose, the Union Ministry of Health would be making an advance payment of Rs 1,500 crore to Biological E.
The Covid-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trials after showing promising results in Phase 1 and 2 clinical trials. The vaccine being developed by Biological-E is a receptor-binding domain (RBD) protein sub-unit vaccine and is likely to be available in the next few months.
The proposal of Biological-E was examined and recommended for approval after due diligence by the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC).
The arrangement with Biological-E is part of the wider endeavour of the Government of India to encourage indigenous vaccine manufacturers by providing them support in Research & Development (R&D) and also financial support.
Biological-E Covid vaccine candidate has been supported by Government of India from preclinical stage to Phase-3 studies. Department of Biotechnology has not only provided financial assistance in terms of grant-in-aid of over Rs 100 crore but has also partnered with Biological-E to conduct all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute (THSTI), Faridabad.
Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.